Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast Cancer Providence, RI, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jack A. Elias, MD, PhD, and colleagues have published new research in the Journal of Immunology that expands understanding of how CHI3L1 inhibits the body’s natural imm

Acuity Brands Q4 Earnings: 2.2% Topline Growth, Margin Boost, Strong Cash Flow And More

Lighting and building management firm Acuity Brands, Inc. (NYSE:AYI) reported fiscal fourth-quarter 2024 net sales growth of 2.2% year over year to $1.03 billion, beating the analyst consensus estimate of $1.02 billion. It clocked an adjusted EPS of $4.30, beating the analyst consensus estimate of $4.28. Sales by segments: Acuity Brands Lighting (ABL) and Lighting Controls revenue hit $955.0 million (+1.1% Y/Y), and Intelligent Spaces Group (ISG) clocked $83.9 million (+16.7% Y/Y). The consolida

Acuity Brands (AYI) Q4 Earnings and Revenues Beat Estimates

Acuity Brands (AYI) delivered earnings and revenue surprises of 2.63% and 2.32%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?

Acuity Brands (NYSE:AYI) Exceeds Q3 Expectations

Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) announced better-than-expected revenue in Q3 CY2024, with sales up 2.2% year on year to $1.03 billion. Its non-GAAP profit of $4.30 per share was also 2.3% above analysts’ consensus estimates.

Acuity Brands Reports Fiscal 2024 Fourth-Quarter and Full-Year Results

Strong Execution in the Fourth-Quarter Delivered Net Sales Growth, Margin Expansion, and Higher EPS with Significant Cash Flow GenerationIncreased Fiscal Q4 2024 Net Sales 2% to $1.03B Compared to the Prior Year Reported Fiscal Q4 2024 Diluted EPS of $3.77, up 43% Over the Prior Year; Adjusted Diluted EPS of $4.30, up 8% Over the Prior YearDelivered Fiscal 2024 Net Sales of $3.8B, a 3% Decline Compared to the Prior Year Reported Fiscal 2024 Diluted EPS of $13.44, up 25% Over the Prior Year; Adju

Acuity Brands Earnings: What To Look For From AYI

Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) will be reporting results tomorrow before the bell. Here’s what to look for.

Carnival Cruises Into Earnings Near Buy Point; Nike, Acuity Brands Also Set To Report

Nike and Conagra headline the latest earnings calendar, along with cruise line operator Carnival, which isn't far from a 52-week high.

Acuity Brands Declares Quarterly Dividend

Atlanta, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Acuity Brands, Inc. (NYSE: AYI; "Company") today declared a quarterly dividend of 15 cents per share. The dividend is payable on November 1, 2024, to shareholders of record on October 18, 2024. About Acuity Brands Acuity Brands, Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light, and more things to come. Through our two business segments, Acuity Brands Light

• 
  Acuity Brands Earnings: What To Look For From AYI

  StockStory
• 
  Acuity Brands (AYI) Q4 Earnings and Revenues Beat Estimates

  Zacks

The Real Good Food Company Announces Debt Refinancing Transactions with PMC Financial Services and Emblem Investments Fund I, LP

Emblem Financing Provides Significant Incremental Liquidity to Drive Operational Turnaround Supporting Continued Growth CHERRY HILL, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods company, today announced it has amended its existing financing with PMC Financial Services Group, LLC (“PMC”) and entered into an agreement with Emblem Investments Fund I, LP (“Embl